Torrent Pharma Recalls Banophen Oral Solution Due to Bacterial Contamination Risk
Torrent Pharma Inc is recalling Banophen Oral Solution due to potential contamination with Burkholderia cepacia and Ralstonia pickettii.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (bacterial contamination) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.
Plain-English summary
Torrent Pharma Inc is recalling Banophen Oral Solution, Sugar Free, Alcohol Free, Cherry Flavor, containing diphenhydramine hydrochloride. The recall involves 655,104 bottles in 4 Fl. oz. and One Pint sizes. The product was distributed to 9 distributors, direct accounts, and relabelers who may have further distributed the product throughout the United States.
The recall was initiated due to cGMP deviations that created a potential for product contamination with Burkholderia cepacia (B. cepacia) and Ralstonia pickettii (R. pickettii). The source text does not report any specific illnesses or injuries associated with the use of this product.
Consumers should stop using the recalled product and check their inventory for the specific lot numbers and expiration dates listed in the official recall notice. The affected lots include various batches with expiration dates ranging from 05/2019 to 10/2020.
The recalled product
- Product
- Banophen Oral Solution, Sugar Free, Alcohol Free, Cherry Flavor, (Diphenhydramine HCl, USP) Each teaspoonful contains diphenhydramine hydrochloride, USP 12.5 mg, a) 4 Fl. oz. (118 mL) bottle, NDC: 0904-1228-00, b) One Pint (473 mL) bottle, NDC: 0904-5174-16, Distributed by Major
- Manufacturer
- Torrent Pharma Inc
- Category
- Drug — Oral Solution
- Hazard
- Affected units
- 655,104
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: a)17E018
- 17E020
- 17E026
- Exp. 05/2019
- 17H008
- 17H018
- 17H028
- Exp. 08/2019
- 17J002
- 17J025
- 17J028
- Exp. 09/2019
- 17L035
- Exp. 11/2019
- 17M024
- Exp. 12/2019
- 18A017
- Exp. 01/2020
- 18B016
- Exp. 02/2020
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 41 recalled by Torrent Pharma Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 41 products in this recall →Related recalls
Same manufacturer · Torrent Pharma Inc
See all →- HighFluoxetine Tablets USP 20 mg Recalled for N-Nitroso Contamination
FDA (Drugs) · 2025-06-11
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11
- High
- ModerateCarbamazepine tablets recalled for failed dissolution specifications
FDA (Drugs) · 2022-01-19
- ModerateTelmisartan and Hydrochlorothiazide Tablets Recalled for Superpotency
FDA (Drugs) · 2021-12-22
Same hazard · bacterial contamination
See all →- HighClorox Recalls Scented Mistolin and Lestoil Cleaners in Puerto Rico
CPSC · 2026-09-03
- HighCurry chicken salad flagged for possible Listeria contamination in two states
USDA FSIS · 2026-07-30
- ModerateMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- SevereSurgical Convenience Kit Recalled for Bacterial Contaminant in Alcohol Prep Pads
FDA (Devices) · 2026-07-08